Lidocaine Epinephrine is one of 24 small molecule programs targeting Complication. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
33 competitors in Radius Fracture
Toradol
Medrol
Decadron
Tylenol
Advil
Celebrex
Xylocaine
Precedex
Ketalar
Arcoxia
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details